BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33567896)

  • 1. Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy.
    Walters BK; Garrett SL; Aden JK; Williams GM; Butler-Garcia SL; Newberry TR; Mckinlay AJ
    Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1064-1068. PubMed ID: 33567896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
    Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.
    Dincer N; Balci S; Yazgan A; Guney G; Ersoy R; Cakir B; Guler G
    Cytopathology; 2013 Dec; 24(6):385-90. PubMed ID: 23078633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Children and Adolescents with Thyroid Nodules: A Single Center Experience.
    Elmaoğulları S; Özalkak Ş; Çetinkaya S; Karaman İ; Üner Ç; Arda N; Savaş-Erdeve Ş; Aycan Z
    J Clin Res Pediatr Endocrinol; 2021 Aug; 13(3):276-284. PubMed ID: 33374093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience.
    Shrestha RT; Evasovich MR; Amin K; Radulescu A; Sanghvi TS; Nelson AC; Shahi M; Burmeister LA
    Thyroid; 2016 Aug; 26(8):1068-76. PubMed ID: 27283257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Testing Has Limited Utility in the Surgical Evaluation of Bethesda III Thyroid Nodules.
    Scola WH; Linhares SM; Handelsman RS; Picado O; Khan ZF; Farrá JC; Lew JI
    J Surg Res; 2021 Dec; 268():209-213. PubMed ID: 34358733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups.
    García Pascual L; Surralles ML; Morlius X; Garcia Cano L; González Mínguez C
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):577-583. PubMed ID: 30262240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
    Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of surgeon-performed ultrasound-guided fine-needle aspiration of thyroid nodules.
    Bohacek L; Milas M; Mitchell J; Siperstein A; Berber E
    Ann Surg Oncol; 2012 Jan; 19(1):45-51. PubMed ID: 21633868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid nodules classified as atypia or follicular lesions of undetermined significance deserve further research: Analysis of 305 surgically confirmed nodules.
    Turkyilmaz S; Ulusahin M; Celebi B; Cekic AB; Mungan S; Kucuktulu U; Tasdelen A; Guner A; Cinel A
    Cytopathology; 2017 Oct; 28(5):391-399. PubMed ID: 28714532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: A retrospective cohort analysis.
    Seagrove-Guffey MA; Hatic H; Peng H; Bates KC; Odugbesan AO
    Cancer Cytopathol; 2018 Oct; 126(10):881-888. PubMed ID: 30335212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy outcomes and the impact of repeat fine needle aspiration of thyroid nodules with Bethesda category III cytology: A multicenter experience.
    Köseoğlu D; Özdemir Başer Ö; Çetin Z
    Diagn Cytopathol; 2021 Oct; 49(10):1110-1115. PubMed ID: 34196509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bethesda Category III, IV, and V Thyroid Nodules: Can Nodule Size Help Predict Malignancy?
    Kiernan CM; Solórzano CC
    J Am Coll Surg; 2017 Jul; 225(1):77-82. PubMed ID: 28223197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of repeat fine-needle aspiration in thyroid nodules categorized as atypia of undetermined significance or follicular lesion of undetermined significance: A single center experience.
    Marin F; Murillo R; Diego C; Jodar E; Acevedo A
    Diagn Cytopathol; 2021 Mar; 49(3):412-417. PubMed ID: 33252841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
    Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
    Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Kuru B; Atmaca A; Tarim IA; Kefeli M; Topgul K; Yoruker S; Elmali M; Danaci M
    Eur J Surg Oncol; 2016 Jan; 42(1):87-93. PubMed ID: 26527545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High risk of malignancy in cases with atypia of undetermined significance on fine needle aspiration of thyroid nodules even after exclusion of NIFTP.
    Özkara SK; Bayrak BY; Turan G
    Diagn Cytopathol; 2020 Nov; 48(11):986-997. PubMed ID: 32745375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration.
    Teixeira GV; Chikota H; Teixeira T; Manfro G; Pai SI; Tufano RP
    World J Surg; 2012 Jan; 36(1):69-74. PubMed ID: 22057754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the Bethesda criteria risk stratification of thyroid nodules.
    Deniwar A; Hambleton C; Thethi T; Moroz K; Kandil E
    Pathol Res Pract; 2015 May; 211(5):345-8. PubMed ID: 25796296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III.
    Huang J; Shi H; Song M; Liang J; Zhang Z; Chen X; Liu Y; Wang S; Wu Z
    Front Endocrinol (Lausanne); 2021; 12():686849. PubMed ID: 34594299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.